Xilinx, Inc. (NASDAQ: XLNX), Accenture Plc (NYSE: ACN), The Fresh Market Inc (NYSE: TFM), Accretive Health, Inc. (NYSE: AH), Oneok Partners LP (NYSE: OKS) and AMETEK, Inc. (NYSE: AME) had their ratings on them reiterated by analysts.
JPMorgan Chase & Co. (NYSE:JPM) reiterated its “Overweight” rating on Xilinx, Inc. (XLNX).
Morgan Stanley (NYSE:MS) reiterated its “Overweight” rating on Accenture Plc (ACN).
JPMorgan Chase & Co. reiterated its “Overweight” rating on The Fresh Market Inc. (TFM).
JPMorgan Chase & Co. reiterated its “Overweight” rating on Accretive Health, Inc. (AH). They have a price target of $35.00 on the company.
Oppenheimer Oneok reiterated its “Outperform” rating on Partners LP (OKS).
Oppenheimer reiterated its “Outperform” rating on AMETEK, Inc. (AME).
No comments:
Post a Comment